Skip to main content
Log in

Antitumor necrosis factor-induced neutropenia: a case report with double positive rechallenges

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

A 50-year-old man with ankylosing spondylitis who developed neutropenia after treatment of etanercept, with two positive rechallenges, and after the first infliximab infusion, is described. Although leukopenia and neutropenia related to etanercept and infliximab have been described as rare adverse events from clinical trials data, their mechanism of action are unknown. This patient developed recurrent mild neutropenia after exposition of two different antitumor necrosis factors; therefore, it seems to be an adverse reaction related to the therapeutic group. Doctors should be aware of this potentially severe adverse effect in patients treated with antitumor necrosis factor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Khanna D, McMahon M, Furst DE (2004) Safety of tumor necrosis factor-α antagonists. Drug Saf 27:307–324

    Article  PubMed  CAS  Google Scholar 

  2. Day R (2002) Adverse reactions of TNF-α inhibitors in rheumatoid arthritis. Lancet 359:540–541

    Article  PubMed  Google Scholar 

  3. Hyrich KL, Silman AJ, Watson KD, Symmons DPM (2004) Anti-tumor necrosis factor α therapy in rheumatoid arthritis: an update on safety. Ann Rheum Dis 63:1538–1543

    Article  PubMed  CAS  Google Scholar 

  4. Fleischmann R, Iqbal I, Nandeshwar P, Quiceno A (2002) Safety and efficacy of disease-modifying anti-rheumatic agents. Drug Saf 25:173–197

    Article  PubMed  CAS  Google Scholar 

  5. Malgarini RB, Pimpinella G (2004) Etanercept and methotrexate in rheumatoid arthritis. Lancet 363:1733

    Article  PubMed  Google Scholar 

  6. Feltelius N, Fored CM, Blomqvist P, Bertilsson L, Geborek P, Jacobsson LT et al (2005) Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept. Ann Rheum Dis 64:246–252

    Article  PubMed  CAS  Google Scholar 

  7. Berliner N, Horwitz M, Loughran TP (2004) Congenital and acquired neutropenia. Hematology (Am Soc Hematol Educ Program) 2004:63–79

    Google Scholar 

  8. Strom BL, Carson JL, Schinnar R, Snyder ES, Shaw M, Lundin FE Jr (1993) Nonsteroidal anti-inflammatory drugs and neutropenia. Arch Intern Med 153:2119–2124

    Article  PubMed  CAS  Google Scholar 

  9. Vidal F, Fontova R, Richart C (2003) Severe neutropenia and thrombocytopenia associated with infliximab. Ann Intern Med 139:W–W63

    PubMed  Google Scholar 

  10. Ghavami A, Genevay S, Fulpius T, Gabay C (2005) Etanercept in treatment of Felty’s syndrome. Ann Rheum Dis 64:1090–1091

    Article  PubMed  CAS  Google Scholar 

  11. Genovese MC, Cohen S, Moreland L, Lium D, Robbins S, Newmark R et al (2004) Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate. Arthritis Rheum 50:1412–1419

    Article  PubMed  CAS  Google Scholar 

  12. Phelan C, Wooltorton E (2004) Infliximab and serious hematologic events. Can Med Assoc J 171:1045

    Article  Google Scholar 

  13. Menon Y, Cucurull E, Espinoza LR (2003) Pancytopenia in a patient with scleroderma treated with infliximab. Rheumatology 42:1273–1274

    Article  PubMed  CAS  Google Scholar 

  14. Favalli EG, Varenna M, Sinigaglia L (2005) Drug-induced agranulocytosis during treatment with infliximab in enteropathic spondyloarthropathy. Clin Exp Rheumatol 23:247–250

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. Montané.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Montané, E., Sallés, M., Barriocanal, A. et al. Antitumor necrosis factor-induced neutropenia: a case report with double positive rechallenges. Clin Rheumatol 26, 1527–1529 (2007). https://doi.org/10.1007/s10067-006-0415-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0415-y

Keywords

Navigation